Pregabalin 165MG Extended Release Tablet Titration Protocol
For pregabalin extended release 165mg tablets, start with one tablet daily and increase by one tablet every 7 days as tolerated, with a maximum recommended dose of 330mg daily (two 165mg tablets). 1
Initial Dosing and Titration Schedule
- Start with pregabalin ER 165mg once daily 1
- After 7 days, if tolerated but inadequate response, increase to 330mg once daily (maximum recommended dose) 1, 2
- Take at approximately the same time each day, with or without food 3
Monitoring During Titration
- Monitor for common adverse effects during titration, including:
- Adverse effects are typically dose-dependent and can often be managed with dose reduction rather than discontinuation 5
Special Considerations
- For patients with renal impairment, dose adjustment is necessary as pregabalin is primarily excreted unchanged by the kidneys 1, 6
- For elderly patients, consider a more gradual titration approach due to increased sensitivity to adverse effects 1, 7
- Pregabalin has linear pharmacokinetics, making dosing more predictable compared to gabapentin 1, 6
Efficacy Assessment
- An adequate trial of pregabalin requires approximately 4 weeks to properly evaluate efficacy 1, 7
- Some patients may experience improvement as early as week 1, which may persist throughout treatment 3
- If inadequate response at maximum dose of 330mg daily after 4 weeks, consider alternative treatment options 1, 2
Common Pitfalls to Avoid
- Avoid rapid titration, as this increases the risk of adverse effects; follow the "low and slow" approach 7
- Avoid abrupt discontinuation in patients who have been on high doses for extended periods to prevent withdrawal symptoms 8
- Do not exceed the maximum recommended dose of 330mg daily for the extended-release formulation 2
- Remember that higher doses (>300mg/day) are not consistently more effective but have more adverse effects 1